ARCHIVED GUIDELINES

Listed below are CARI Guidelines which are out-of-date and have been archived.

Archived Guidelines
Chronic Kidney Disease: Kidney Stones
Chronic Kidney Disease: Renovascular Disease
Chronic Kidney Disease: Renal Vasculitis
Chronic Kidney Disease: Type 2 Diabetes: Kidney Disease
Dialysis: Acceptance onto Dialysis
Dialysis Adequacy: Haemodialysis
Dialysis Adequacy: Peritoneal Dialysis
Dialysis: Biochemical and Haematological targets
Dialysis: Peritonitis Treatment & Prophylaxis
Dialysis: Vascular Access
Transplantation: Calcineurin Inhibitors in Renal Transplantation
Transplantation: Care of Kidney Transplant Recipients
Transplantation: CMV Disease
Transplantation: Deceased Kidney Donor Suitability
Transplantation: Living Kidney Donors
Chronic Kidney Disease: Autosomal-dominant polycystic kidney disease (ADPKD)
Chronic Kidney Disease: Prevention of Progression of Kidney Disease
Chronic Kidney Disease: Nutrition and growth in kidney disease
Chronic Kidney Disease: Urine Protein as Diagnostic Test
Chronic Kidney Disease: Evaluation of Renal Function
Chronic Kidney Disease: Cardiovascular Disease
Chronic Kidney Disease: Prevention of Progression of Kidney Disease
Protein intake in children
Vitamins in pre-dialysis patients
ACE inhibitor treatment in diabetic nephropathy
ACE inhibitor and angiotensin II antagonist combination treatment
Acidosis
Analgesic-associated kidney disease
Angiotensin II antagonist
Antihypertensive therapy in diabetic nephropathy
Blood pressure control: targets
Blood pressure control: role of specific anti-hypertensives
Control of hypercholesterolaemia and progression of diabetic nephropathy
Dietary protein restriction
Early detection of patients with kidney disease
Early referral of patients with pre-end-stage kidney disease
Erythropoietin
Exercise
Focal segmental glomerulosclerosis (FSGS): treatment with steroids
Focal segmental glomerulosclerosis (FSGS): use of cyclosporin A
Focal segmental glomerulosclerosis (FSGS): cytotoxic therapy
Focal segmental glomerulosclerosis (FSGS): correction of secondary causes
Focal segmental glomerulosclerosis (FSGS): use of other therapies
Glucose control and progression of diabetic nephropathy
Lipids
Membranous nephropathy: role of steroids
Membranous nephropathy: role of cyclosporin therapy
Membranous nephropathy: use of other therapies
Membranous nephropathy: role of alkylating agents
Multifactorial therapy and the progression of diabetic nephropathy
Other agents
Other forms of dietary interventions
Phosphate
Pre-dialysis education for patients with chronic kidney disease
Pregnancy
Protein restriction to prevent the progression of diabetic nephropathy
Reducing proteinuria
Reflux nephropathy
Regular and frequent follow-up of patients with pre-end-stage kidney disease
Renal artery stenosis
Smoking
Smoking and the progression of diabetic nephropathy
Specific effects of calcium channel blockers in diabetic nephropathy
Specific management of IgA nephropathy: role of steriod therapy
Specific management of IgA nephropathy: role of fish oil
Specific management of IgA nephropathy: role of triple therapy and cytotoxictherapy
Specific management of IgA nephropathy: role of tonsillectomy
Specific management of IgA nephropathy: role of cyclosporin and other therapies
Treatment of secondary membranous nephropathy
Uric acid
Weight reduction in obese patients with chronic kidney disease